首页|期刊导航|环球中医药|基于Notch/血小板源性生长因子B通路探讨藏医金针促进缺血性卒中大鼠血管新生的机制

基于Notch/血小板源性生长因子B通路探讨藏医金针促进缺血性卒中大鼠血管新生的机制OA

Mechanism of Tibetan golden acupuncture in promoting angiogenesis in rats with ischemic stroke via the Notch/PDGF-B pathway

中文摘要英文摘要

目的 观察藏医金针对大脑中动脉缺血(middle cerebral artery occlusion,MCAO)大鼠血管新生及 Notch/血小板源性生长因子 B(platelet derived growth factor B,PDGF-B)通路相关蛋白表达的影响,探讨藏医金针促进血管新生的机制.方法 选取 SD 大鼠 72 只,7 周龄,体质量260~300 g,随机分为假手术组、模型组、金针组、金针+抑制剂组,每组 18 只.参照 Zea longa 法施行 MCAO 术建立脑缺血大鼠模型.金针组和金针+抑制剂组每日治疗1 次,连续治疗7 次,金针+抑制剂组给予 Notch 通路抑制剂 N-[N-(3,5-二氟苯乙酰)-L-丙氨酰]-S-苯基甘氨酸叔丁酯腹腔注射.假手术组和模型组平行时间抓取,不进行针刺.治疗一周后分别以改良神经功能缺损评分(modified neurological severity scores,mNSS)检测大鼠神经功能缺损程度,激光散斑衬比成像检测脑血流量,TTC 染色检测脑梗死体积,免疫组化检测 PDGF-B 阳性细胞数,蛋白印迹法检测血小板源性生长因子受体 B(platelet-derived growth factor receptor b,PDGFR-B)、δ 样蛋白-4(delta-like protein 4,DLL-4)、锯齿状典型 Notch 配体 1(jagged canonical Notch ligand 1,Jagged-1)、具有 YRPW 基序 1 的hes 相关家族 bHLH 转录因子(hes related family bHLH transcription factor with YRPW motif 1,Hey1)、具有 YRPW 基序2 的 hes 相关家族 bHLH 转录因子(hes related family bHLH transcription factor with YRPW motif 2,Hey2)、发状分裂相关增强子-1(hairy enhancer of split-1,Hes1)、Notch1 的蛋白表达,RT-PCR 检测 PDGFR-B、Hey1、Hey2、Hes1 的 mRNA 表达.结果 与假手术组比较,左右脑血流量比值降低(P<0.01),TTC 见脑梗死明显,PDGF-B 阳性细胞数增加(P<0.05),PDGFR-B、DLL-4、Jagged-1、Hey1、Hey2、Hes1、Notch1 的蛋白表达升高(P<0.05 或 P<0.01),PDGFR-B、Hey1、Hey2、Hes1 的 mRNA 表达升高(P<0.01).与模型组比较,金针组 mNSS 评分降低(P<0.01),左右脑血流量比值升高(P<0.01),脑梗死体积降低(P<0.01),PDGF-B 阳性细胞数增加(P<0.01),PDGFR-B、DLL-4、Jagged-1、Hey1、Hey2、Hes1、Notch1 的蛋白表达升高(P<0.01),PDGFR-B、Hey1、Hey2、Hes1 的mRNA 表达升高(P<0.01).与模型组比较,金针+抑制剂组 mNSS 评分降低(P<0.01),左右脑血流量比值、脑梗死体积和 PDGFR-B、DLL-4、Jagged-1、Hey1、Hey2、Hes1、Notch1 蛋白表达无统计学意义(P>0.05),PDGFR-B、Hey1、Hey2、Hes1 的 mRNA 表达差异均无统计学意义(P>0.05).与金针组比较,金针+抑制剂组 mNSS 评分升高(P<0.01),左右脑血流量之比降低(P<0.05),脑梗死体积增加(P<0.01),PDGF-B 阳性细胞数降低(P<0.01),PDGFR-B、DLL-4、Jagged-1、Hey1、Hey2、Hes1、Notch1蛋白表达降低(P<0.01),PDGFR-B、Hey1、Hey2、Hes1 对应的 mRNA 表达降低(P<0.01).结论 藏医金针上调 Notch 通路中 DLL-4、Jagged-1、Hey1、Hey2、Hes1、Notch1 蛋白的表达,增加 PDGF-B 和PDGFR-B 的表达,促进血管新生,增加患侧脑血流量,减少梗死体积,减轻 MCAO 大鼠神经功能损伤.

Objective To observe the effect of Tibetan golden acupuncture on angiogenesis and the expression of Notch/PDGF-B pathway proteins in MCAO rats,so as to explore the mechanism of Tibetan golden acupuncture in promoting angiogenesis.Methods SD rats were randomly divided into sham-operation group,a model group,a Tibetan golden acupuncture group,and a Tibetan golden acupuncture plus inhibitor group,with 18 rats in each group.The MCAO model was established by Zea Longa method.The Tibetan golden acupuncture group and the Tibetan golden acupuncture+inhibitor group were treated once a day for seven consecutive times,and the Notch pathway inhibitor DAPT was given in-traperitoneal injection in the Tibetan golden acupuncture+inhibitor group.The sham-operation group and the model group were handled in parallel for the same duration without acupuncture.modified neurological severity scores(mNSS)score was used to detect the degree of neurological deficit,laser speckle contrast imaging was used to detect cerebral blood flow,TTC staining enabled the detection of cerebral infarction volume,immunohistochemistry was used to detect the number of platelet-derived growth factor B(PDGF-B)-positive cells.The protein expressions of platelet-derived growth factor receptor B(PDGFR-B),DLL-4,Jagged-1,Hey1,Hey2,Hes1,and Notch1 were detected by Western blot.PDGFR-B,DLL-4,Jagged-1,Hey1,Hey2,Hes1,Notch1 protein expression,and the mRNA expression of PDGFR-B,Hey1,Hey2,Hes1 were detected by RT-PCR.Results Compared with the sham-operation group,the ratio of left and right cerebral blood flow was decreased(P<0.01),TTC showed obvious cerebral infarction,and the number of PDGF-B-positive cells was increased in the model group(P<0.05).The protein expression of PDGFR-B,DLL-4,Jagged-1,Hey1,Hey2,Hes1 and Notch1 was increased(P<0.05 or P<0.01).The corresponding mRNA expressions of PDGFR-B,Hey1,Hey2 and Hes1 were increased(P<0.01).Compared with the model group,the mNSS score was decreased(P<0.01),the ratio of left and right cerebral blood flow was increased(P<0.01),the cerebral infarction volume was decreased(P<0.01),and the number of PDGF-B positive cells was increased(P<0.01)in the Tibetan golden acupuncture group.The protein expressions of PDGFR-B,DLL-4,Jagged-1,Hey1,Hey2,Hes1 and Notch1 were increased(P<0.01).The corresponding mRNA expressions of PDGFR-B,Hey1,Hey2 and Hes1 were in-creased(P<0.01).Compared with the model group,no significant differences were observed in the ratio of left and right cerebral blood flow,cerebral infarction volume,or the protein and mRNA expressions of PDGFR-B,DLL-4,Jagged-1,Hey1,Hey2,Hes1,and Notch1 in the Tibetan golden acupuncture plus inhibitor group(P>0.05),although the mNSS score was reduced(P<0.01).No significant differences were found in the mRNA expressions of PDGFR-B,Hey1,Hey2,and Hes1(P>0.05).Compared with the Tibetan golden acupuncture group,the mNSS score was increased(P<0.01),the ratio of left and right cerebral blood flow was decreased(P<0.05),the cerebral infarction volume was increased(P<0.01),and the number of PDGF-B positive cells was decreased(P<0.01)in the Tibetan golden acupuncture+inhibitor group.PDGFR-B,DLL-4,Jagged-1,Hey1,Hey2,Hes1,Notch1 protein expression decreased(P<0.01).The corresponding mRNA expressions of PDGFR-B,Hey1,Hey2 and Hes1 were decreased(P<0.01).Conclusion Tibetan golden acupuncture can upregulate the expressions of DLL-4,Jagged-1,Hey1,Hey2,Hes1 and Notch1 proteins in the Notch pathway,increase the expressions of PDGF-B and PDGFR-B,promote angiogenesis,increase cerebral blood flow on the affected side,reduce the infarct volume,and alleviate neurological damage in MCAO rats.

袁钰轩;刘雅儒;高源洁;陈健鹏;齐榕明;于小涵;刘柏宏;益西拉姆;靳贵林;徐立军

850000 拉萨,西藏藏医药大学藏医药研究所||北京中医药大学中医学院850000 拉萨,西藏藏医药大学藏医药研究所||北京中医药大学针灸推拿学院北京中医药大学第三附属医院针灸科北京中医药大学第三附属医院针灸科北京中医药大学研究生院北京中医药大学针灸推拿学院北京中医药大学针灸推拿学院850000 拉萨,西藏藏医药大学实验标本中心850000 拉萨,西藏藏医药大学实验标本中心850000 拉萨,西藏藏医药大学藏医药研究所

医药卫生

藏医学藏医金针隆病集驺穴Notch/血小板源性生长因子B通路缺血性卒中血管新生

Tibetan medicineTibetan golden acupunctureLong diseaseJizou pointNotch/PDGF-B pathwaycerebral ischemia strokeangiogenesis

《环球中医药》 2026 (3)

484-494,11

西藏自治区自然科学基金项目(XZ202301ZR0025G、XZ202401ZR0032)

10.3969/j.issn.1674-1749.2026.03.010

评论